Melinta Therapeutics, Inc. (MLNT) financial statements (2021 and earlier)

Company profile

Business Address 44 WHIPPANY ROAD
MORRISTOWN, NJ 07963
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82128232154999770
Cash and cash equivalents82128232154999770
Restricted cash and investments00     
Receivables(0)86822 
Inventory, net of allowances, customer advances and progress billings4111   
Inventory4111     
Prepaid expense 21130
Prepaid expense and other current assets0
Other undisclosed current assets260     
Total current assets:1491502381621059970
Noncurrent Assets
Property, plant and equipment2200000
Intangible assets, net (including goodwill)2298   
Intangible assets, net (excluding goodwill)2298     
Deposits noncurrent assets  00000
Other noncurrent assets611    
Total noncurrent assets:2921100000
TOTAL ASSETS:4421602391621059971
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities553223131583
Accounts payable17716101262
Accrued liabilities342431100
Employee-related liabilities  42211
Interest and dividends payable40  0  
Debt  74422
Derivative instruments and hedges, liabilities     1 
Deferred revenue and credits    0 
Other undisclosed current liabilities78   (0)  
Total current liabilities:13432301818115
Noncurrent Liabilities
Long-term debt and lease obligation1104091515138
Long-term debt, excluding current maturities1104091515138
Liabilities, other than long-term debt7171711116 
Deferred revenue and credits101711116 
Other liabilities77     
Total noncurrent liabilities:11856262726188
Total liabilities:252885544442913
Stockholders' equity
Stockholders' equity attributable to parent, including:19072183118617058
Common stock0000000
Additional paid in capital910645620437289236179
Accumulated deficit(720)(573)(437)(319)(228)(166) 
Other undisclosed stockholders' equity attributable to parent      (121)
Other undisclosed stockholders' equity      (179)
Total stockholders' equity:190721831186170(121)
Other undisclosed liabilities and equity      179
TOTAL LIABILITIES AND EQUITY:4421602391621059971

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues96341827158 
Revenue, net341822158 
Cost of revenue
(Cost of Goods and Services Sold)
(41)      
Gross profit:55341827158 
Operating expenses(255)(113)(135)(116)(75)(51)(23)
Other undisclosed operating income41      
Operating loss:(158)(79)(117)(89)(59)(43)(23)
Nonoperating income (expense)120(1)(2)(2)(2)(1)
Other nonoperating income (expense)120(1)(2)(2)(2)(1)
Interest and debt expense(46)(4)(1)(0)(2)(2)(1)
Loss from continuing operations before equity method investments, income taxes:(203)(63)(119)(91)(64)(47)(26)
Other undisclosed income from continuing operations before income taxes      1
Net loss:(203)(63)(119)(91)(64)(47)(24)
Other undisclosed net income attributable to parent4641022 
Net loss attributable to parent:(157)(59)(118)(91)(62)(45)(24)
Other undisclosed net loss available to common stockholders, basic (19)    (0)
Net loss available to common stockholders, diluted:(157)(78)(118)(91)(62)(45)(25)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(203)(63)(119)(91)(64)(47)(24)
Comprehensive loss, net of tax, attributable to parent:(203)(63)(119)(91)(64)(47)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: